These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 922743)
1. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. Inaba M; Johnson RK Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743 [TBL] [Abstract][Full Text] [Related]
2. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D. Wilkoff LJ; Dulmadge EA J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559 [TBL] [Abstract][Full Text] [Related]
3. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Inaba M; Kobayashi H; Sakurai Y; Johnson RK Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418 [TBL] [Abstract][Full Text] [Related]
4. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
5. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
6. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy. Yanovich S; Taub RN Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858 [TBL] [Abstract][Full Text] [Related]
7. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone. Gutierrez PL; Wilder PJ; Biswal N Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972 [TBL] [Abstract][Full Text] [Related]
8. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184. Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin B1. Valeriote F; Medoff G; Dieckman J Cancer Res; 1979 Jun; 39(6 Pt 1):2041-5. PubMed ID: 445402 [TBL] [Abstract][Full Text] [Related]
10. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Johnson RK; Chitnis MP; Embrey WM; Gregory EB Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555 [TBL] [Abstract][Full Text] [Related]
11. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity. Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840 [TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells. Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962 [TBL] [Abstract][Full Text] [Related]
13. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Ganapathi R; Grabowski D; Rouse W; Riegler F Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165 [TBL] [Abstract][Full Text] [Related]
16. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells. Tapiero H; Nguyen-Ba G; Lampidis TJ Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786 [TBL] [Abstract][Full Text] [Related]
17. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695 [TBL] [Abstract][Full Text] [Related]
18. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602 [TBL] [Abstract][Full Text] [Related]
19. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells. Papahadjopoulos D; Poste G; Vail WJ; Biedler JL Cancer Res; 1976 Sep; 36(9 pt.1):2988-94. PubMed ID: 975068 [TBL] [Abstract][Full Text] [Related]
20. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia. Inaba M; Sakurai Y Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]